Find Academic Supervisors

• Cardiac biology
• Epithelial physiology
• Developmental biology
• +5 more

Dr. Ilan Ruhr is a comparative physiologist at the University of Salford's School of Science, Engineering & Environment. His research focuses on how environmental factors impact the phenotype of aquatic vertebrates, with special expertise in cellular physiology of epithelial and cardiac cells and their underlying molecular mechanisms. His research interests include: Cardiac biology Epithelial physiology Developmental biology Ion homeostasis Osmoregulation Mitochondrial biology Dr. Ruhr's recent research publications demonstrate a strong focus on anoxia tolerance in turtles, with particular attention to developmental programming of cardiac function. His work spans comparative studies across multiple species including marine teleosts, freshwater turtles, and other vertebrates. He has made significant contributions to understanding how environmental stressors affect physiological function at multiple biological levels. His scientific awards include: University of Salford Research Fellowship (2024) CARTOX, LLC research grant (£10,000 GBP, 2020) Multiple Company of Biologists Travel Fellowships (2015, 2018) RSMAS Five-Year Graduate Research Assistantship ($105,000 USD, 2011) Dr. Ruhr actively supervises graduate students and maintains a robust network of international collaborations. His research program aligns with UN Sustainable Development Goals related to health, climate action, marine conservation, and terrestrial ecosystem sustainability. He has served on editorial boards, organized scientific conferences, and participated in numerous public engagement activities to disseminate science to broader audiences.

Julio Altamirano BarreraView profile

Associate Professor

• Cardiovascular Physiology
• Molecular Cardiology
• Calcium Signaling
• +3 more

Dr. Julio Altamirano Barrera serves as Associate Professor at Tecnologico de Monterrey's School of Medicine and Health Sciences (Campus Chihuahua), where he has been faculty since 2009. His academic appointments include leadership in the Prevención Strategic Research Group and affiliation with the National System of Researchers (Level 2). He teaches undergraduate and graduate courses including Pathophysiology of Cardiovascular System and Thesis supervision. Bachelor of Biology (Honors), National Autonomous University of Mexico Ph.D. in Cell and Molecular Physiology, Loyola University Chicago (2004) Postdoctoral Training: Loyola University Chicago (2004-2005) and University of Maryland at Baltimore (2005-2009, AHA Fellowship) His research centers on molecular mechanisms of calcium signaling in cardiac pathologies , particularly heart failure and ventricular arrhythmias. Using animal models of metabolic diseases, his lab employs confocal microscopy, cellular electrophysiology, and molecular biology techniques to investigate SERCA2a/RyR2 dysfunction, oxidative stress, and T-tubule remodeling. Current work explores H2S therapy for cardiac hypertrophy and intermittent fasting applications in heart failure. Analysis of his 15 most recent publications reveals dominant themes in calcium handling pathologies (80% of articles), with strong focus on metabolic syndrome complications (60%) and emerging work in natural compound therapeutics (20%). Key techniques include confocal calcium imaging (73%) and molecular analysis of cardiac proteins (67%). National System of Researchers Level 2 Certification (CONACYT) American Heart Association Postdoctoral Fellowship Dr. Altamirano has graduated 7 Master's students, 1 Ph.D. candidate, and mentored 1 Postdoctoral Fellow . His research is supported through institutional grants at Tecnologico de Monterrey, with recent projects examining cardiac calcium dynamics in diabetic models and therapeutic interventions for hypertensive heart disease. He actively participates in the Sustainable Development Goals initiative, particularly Good Health and Well-being (SDG 3) and Industry Innovation (SDG 9). His laboratory focuses on cardiac biophysics and molecular pathology , utilizing rat models of metabolic syndrome, diabetes, and cardiac injury. Current projects investigate H2S-based therapies, intermittent fasting protocols, and natural antimicrobial compounds with potential cardiovascular applications.